Mechanistically, we found that C36L1 binds to the MIF receptor CD74 on MOs and DCs, thereby inhibiting MIF immunosuppressive effect on these innate immune cells, and shifting the balance from an immunosuppressive tumor microenvironment into a pro-inflammatory immunogenic environment in which the antitumor immune response is reinvigorated. The gene discussed is CD74; the disease is neoplasm.